WONDERTOX 100U

WONDERTOX® is a highly purified Botulinum Toxin Type A injectable product developed for both aesthetic and therapeutic applications. Manufactured under strict quality standards in South Korea, it is designed to temporarily reduce muscle activity by blocking nerve signals to targeted muscles. This action helps smooth dynamic facial wrinkles and manage certain neuromuscular disorders.

The product is approved by the Korean Ministry of Food and Drug Safety (MFDS, formerly KFDA) and is supplied as a sterile, vacuum-dried powder for reconstitution prior to injection.

Origin

• Product Name: WONDERTOX® 100U

• Active Ingredient: Clostridium Botulinum Toxin Type A

• Country of Origin: South Korea

• Manufacturer: South Korea

• Regulatory Status: Approved by the Korean Ministry of Food and Drug Safety (MFDS)

Composition

Each vial contains:

Mechanism of Action

WONDERTOX® works by inhibiting the release of acetylcholine at the neuromuscular junction. This temporary interruption of nerve signaling reduces muscle contractions, leading to localized muscle relaxation. The effect is reversible and gradually diminishes as nerve function recovers over time.

Indications

Aesthetic Indications

• Temporary improvement of moderate to severe glabellar lines (frown lines) between the eyebrows

• Reduction of dynamic facial wrinkles caused by repetitive muscle movement

• Facial rejuvenation through muscle relaxation and wrinkle smoothing

Therapeutic Indications

• Benign essential blepharospasm

• Hemifacial spasm

• Muscle spasticity associated with neurological disorders

• Equinus foot deformity in pediatric patients with cerebral palsy

• Other approved neuromuscular conditions as determined by local regulatory guidelines

Key Benefits

• High-purity Botulinum Toxin Type A formulation

• Effective reduction of dynamic facial wrinkles

• Precise and predictable clinical performance

• Temporary and reversible muscle relaxation

• Suitable for both cosmetic and therapeutic applications

• Manufactured according to stringent pharmaceutical quality standards

Administration

WONDERTOX® should be reconstituted with sterile, preservative-free 0.9% sodium chloride solution before use.

General Guidelines

• Administer via intramuscular injection.

• Dosage and injection sites should be determined according to the treatment indication and individual patient characteristics.

• Use aseptic techniques during preparation and administration.

• Treatment should be performed by qualified healthcare professionals experienced in botulinum toxin procedures.

Storage

Unopened Vials

• Store refrigerated at 2°C to 8°C or according to local product labeling requirements.

• Protect from direct light.

• Do not expose to excessive heat or repeated freeze-thaw cycles.

Shelf Life

• Up to 36 months from the manufacturing date when stored under recommended conditions.

Reconstituted Product

• Store at 2°C to 8°C.

• For optimal safety and efficacy, use within 24 hours after reconstitution.

Expected Duration of Effect

Clinical effects typically begin to appear within several days after treatment, with maximum results generally observed within 1–2 weeks. The duration of action varies depending on the treatment area and individual patient factors but commonly lasts between 3 and 6 months.

Contraindications

WONDERTOX® should not be used in patients with:

• Known hypersensitivity to Botulinum Toxin Type A or any formulation component

• Infection or inflammation at the intended injection site

• Certain neuromuscular disorders, unless specifically advised by a healthcare professional

Possible Side Effects

As with other Botulinum Toxin Type A products, potential adverse reactions may include:

• Injection-site pain, redness, or swelling

• Temporary localized muscle weakness

• Headache

• Eyelid drooping (ptosis)

• Dry eyes or excessive tearing

• Flu-like symptoms

• Allergic reactions (rare)

Most adverse effects are mild to moderate and temporary.

Packaging

• 1 vial containing 100 Units of Botulinum Toxin Type A sterile powder for injection.